The Senate passes a bipartisan amendment introduced by Sens. Chuck Grassley (R-IA) and Dick Durbin (D-IL) requiring pharmaceutical companies to list p...
FDA grants Dthera Sciences a breakthrough device designation, for its Alzheimers treatment, DTHR-ALZ.
FDA releases a report summarizing its 4/16 public workshop on clinical trial inclusion and exclusion.
Federal Register notice: FDA seeks comments on an information collection extension entitled Sun Protection Factor Labeling and Testing Requirements fo...
Federal Register notice: FDA makes available a draft guidance entitled Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, and...
Federal Register notice: FDA requests nominations for voting members to serve on the Device Good Manufacturing Practice Advisory Committee and device ...
Federal Register notice: FDA determines that Danocrine (danazol) Capsules, 50mg, 100mg, and 200mg, were not withdrawn from sale for reasons of safety ...
FDA classifies as Class 1 a bioMerieux recall of its Vitek 2 Gram Positive Antimicrobial Susceptibility Testing Cards due to false results for some st...